New brain scan agent could spot Parkinson's and MSA early
NCT ID NCT07604116
First seen May 25, 2026 · Last updated May 25, 2026
Summary
This early-phase study tests a new imaging drug called SST001 in 30 healthy adults and people with multiple system atrophy (MSA) or Parkinson's disease. The main goal is to check if SST001 is safe and how it spreads in the body using PET scans. Researchers hope it may help doctors see brain changes linked to these diseases.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE (PD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hospital of Jiangnan University
Wuxi, Jiangsu, 214122, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Huashan Hospital, Fudan University
Shanghai, Shanghai Municipality, 200040, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.